A new investor syndicate bringing together two of Atlanta's prominent research institutions has announced its latest investment into Sanguina, a wellness and diagnostic company offering at-home anemia management tools.
The syndicate is a collaboration between EBFI (the Emory BioFoundry Institute), Invest Georgia, and the Georgia Tech Research Impact Fund. Sanguina's flagship technology is an AI-powered smartphone application that analyzes a fingernail photo to provide insights into blood health and help users monitor indicators associated with iron deficiency and anemia.
The condition impacts close to two billion people worldwide. Sanguina was founded on intellectual property developed at both Georgia Tech and Emory University, getting its app into the app store in 2020.
Co-founders include Erika Tyburski (CEO and Georgia Tech graduate) and Wilbur Lam (Vice President of Entrepreneurship at Emory). The investment represents the growing collaboration between Atlanta's research institutions to support local healthcare entrepreneurs.
